News
08-17-2010, 12:30 AM
An experimental drug called olaparib has been shown to shrink tumours in women whose advanced cancers were caused by faults in their BRCA genes.
More... (http://www.news-medical.net/news/20100817/Experimental-drug-benefits-women-with-advanced-ovarian-or-breast-tumours-caused-by-BRCA-gene-faults.aspx)
More... (http://www.news-medical.net/news/20100817/Experimental-drug-benefits-women-with-advanced-ovarian-or-breast-tumours-caused-by-BRCA-gene-faults.aspx)